MP Doctors Protest Arrest of Dr. Praveen Soni Amidst Cough Syrup Deaths Controversy

Thousands of government doctors in Madhya Pradesh (MP) protested the arrest of Dr. Praveen Soni, a pediatrician implicated in the deaths of 22 children linked to contaminated “Coldrif” cough syrup. The protests erupted in October 2025 across MP, with physicians alleging Dr. Soni was made a scapegoat, urging authorities to focus on the manufacturers and regulatory failures responsible for distributing the toxic medicine containing a poisonous industrial solvent.

Key Findings and Developments:
The tragic deaths occurred due to consumption of “Coldrif” cough syrup, which was found to contain 48.6% diethylene glycol—a highly toxic industrial solvent known to cause acute kidney failure. This syrup had been prescribed for over 30 years in MP, particularly in tribal areas, due to its affordability (~Rs 30 per bottle) compared to costlier alternatives priced over Rs 100. Dr. Soni, who prescribed this syrup considering patients’ financial constraints, was arrested on charges of negligence. However, over 8,500 government doctors statewide protested the arrest, asserting that Dr. Soni was unjustly targeted while the true culpability lies with drug manufacturers and regulatory agencies responsible for safety oversight.​

Expert Perspectives:
Dr. Rakesh Malviya, president of the Progressive Medical Teachers Association of MP (PMTAMP), emphasized that Dr. Soni’s prescribing practices reflected concern for economically disadvantaged populations and that the arrest violates the Supreme Court’s precedent requiring inquiry before prosecuting doctors (Jacob Mathew vs. State of Punjab). He stated, “Instead of prosecuting a doctor who was not involved in manufacturing or distribution, stringent action should be taken against those accountable for approving and supplying adulterated drugs.” Dr. Malviya further demanded capital punishment for manufacturers who endanger children’s lives through toxic medicines. Similarly, Dr. Ankur Batra, Secretary of the Indian Medical Association (IMA) Parasia unit, called for Dr. Soni’s immediate release and urged authorities to act decisively against the true offenders.​

Context and Background:
The “Coldrif” syrup tragedy is part of a larger public health crisis linked to poor drug quality control. Tamil Nadu authorities initially detected the toxic industrial solvent in samples from the syrup, leading to deaths predominantly in MP’s Chhindwara district. Tamil Nadu Directorate of Drug Control declared the syrup “Not of Standard Quality” after testing by the Government Drug Testing Laboratory in Chennai. The incident exposed crucial gaps in drug regulation and quality assurance, with only four drug testing laboratories available in MP, of which only Bhopal’s facility is adequately equipped.​

Implications for Public Health:
This case highlights critical systemic failures impacting drug safety and public health in India, underscoring the urgent need for stricter enforcement of pharmaceutical regulations and comprehensive monitoring of drug manufacturing and distribution channels. The medical community warns that criminalizing physicians for prescribing legally approved medicines may deter doctors from working in underserved areas, potentially compromising healthcare access for vulnerable populations. The doctors’ protest also calls for legislative reforms imposing the harshest penalties on manufacturers producing adulterated, life-threatening medicines to restore public trust in the healthcare system.​

Potential Limitations and Counterarguments:
While the arrest of Dr. Soni has faced unified medical community opposition, authorities maintain ongoing investigations, including a Special Investigation Team (SIT) probe and post-mortem exhumations. Critics argue that accountability should include all parties involved, including physicians’ roles in prescribing potentially harmful drugs. However, expert legal analysts emphasize that arrests without preliminary inquiry against doctors contravene Supreme Court guidelines, risking erosion of medical professional autonomy and morale.​

Practical Implications for Readers:
Readers should be aware that consumption of cough syrups containing adulterants like diethylene glycol poses severe health risks including kidney failure, especially in children. Vigilance regarding medication source and regulatory approvals is crucial. Healthcare providers should balance affordability and safety while prescribing, and patients or caregivers should consult licensed practitioners and buy medicines from trusted pharmacies. This incident serves as a cautionary tale on the consequences of regulatory lapses affecting medicine safety.​

Medical Disclaimer:
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References: